Although the presence of cardiac dysfunction and cardiomyopathy in chronic diabetes has
been recognized, the pathophysiology of diabetes-induced metabolic and subcellular …

With cardiovascular disease (CVD) being a primary source of global morbidity and mortality,
it is crucial that we understand the molecular pathophysiological mechanisms at play …

Angiotensin-converting enzyme (ACE) inhibitors, which prevent the conversion of
angiotensin I to angiotensin II, are well-known for the treatments of cardiovascular diseases …

Heart failure is invariably associated with cardiac hypertrophy and impaired cardiac
performance. Although several drugs have been developed to delay the progression of …

Background Lannea egregia leaf has been used locally for the management of diseases
with limited scientific support. Hence, the cardiomyopathy protective ability of an alkaloid …

Ventricular fibrillation (VF) and sudden cardiac arrest (SCA) remain some of the most
important public health concerns worldwide. For the past 50 years, the recommendation in …

Chronic heart failure is invariably associated with adverse cardiac remodeling and
depressed cardiomyocyte function. The failing heart exhibits a wide variety of alterations in …

Background: Lannea egregia leaf has been used locally for the management of diseases
with limited scientific support. Hence, the cardiomyopathy protective ability of an alkaloid …